| Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer C Yang, SR Gundala, R Mukkavilli, S Vangala, MD Reid, R Aneja Carcinogenesis 36 (6), 656-665, 2015 | 202 | 2015 |
| Hydroxychavicol, a betel leaf component, inhibits prostate cancer through ROS-driven DNA damage and apoptosis SR Gundala, C Yang, R Mukkavilli, R Paranjpe, M Brahmbhatt, V Pannu, ... Toxicology and applied pharmacology 280 (1), 86-96, 2014 | 96 | 2014 |
| Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents VS Gopinath, J Pinjari, RT Dere, A Verma, P Vishwakarma, R Shivahare, ... European journal of medicinal chemistry 69, 527-536, 2013 | 78 | 2013 |
| Application of Combination High-Throughput Phenotypic Screening and Target Identification Methods for the Discovery of Natural Product-Based Combination Drugs AR Isgut M, Rao M, Yang C, Subrahmanyam V, Rida PCG Medicinal Research Reviews, 2017 | 61* | 2017 |
| Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs MJ Zamek-Gliszczynski, KJ Ruterbories, RT Ajamie, ER Wickremsinhe, ... Journal of pharmaceutical sciences 100 (6), 2498-2507, 2011 | 59 | 2011 |
| Early detection and staging of chronic liver diseases with a protein MRI contrast agent M Salarian, RC Turaga, S Xue, M Nezafati, K Hekmatyar, J Qiao, Y Zhang, ... Nature communications 10 (1), 4777, 2019 | 57 | 2019 |
| Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract SR Gundala, R Mukkavilli, C Yang, P Yadav, V Tandon, S Vangala, ... Carcinogenesis 35 (6), 1320-1329, 2014 | 57 | 2014 |
| Absorption, metabolic stability, and pharmacokinetics of ginger phytochemicals R Mukkavilli, C Yang, R Singh Tanwar, A Ghareeb, L Luthra, R Aneja Molecules 22 (4), 553, 2017 | 52 | 2017 |
| Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics R Mukkavilli, SR Gundala, C Yang, S Donthamsetty, G Cantuaria, ... PloS one 9 (9), e108386, 2014 | 47 | 2014 |
| Aminothiazoles: Hit to lead development to identify antileishmanial agents D Bhuniya, R Mukkavilli, R Shivahare, D Launay, RT Dere, A Deshpande, ... European journal of medicinal chemistry 102, 582-593, 2015 | 46 | 2015 |
| Purification of lysozyme from other hen's‐egg‐white proteins using metal‐affinity precipitation I Roy, MVS Rao, MN Gupta Biotechnology and applied biochemistry 37 (1), 9-14, 2003 | 42 | 2003 |
| In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis R Mukkavilli, J Pinjari, B Patel, S Sengottuvelan, S Mondal, A Gadekar, ... European journal of pharmaceutical sciences 65, 147-155, 2014 | 37 | 2014 |
| Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs VS Gopinath, M Rao, R Shivahare, P Vishwakarma, S Ghose, A Pradhan, ... Bioorganic & medicinal chemistry letters 24 (9), 2046-2052, 2014 | 34 | 2014 |
| An integrated process for purification of lysozyme, ovalbumin, and ovomucoid from hen egg white I Roy, MVS Rao, MN Gupta Applied biochemistry and biotechnology 111, 55-63, 2003 | 34 | 2003 |
| Pharmacokinetic-pharmacodynamic correlations in the development of ginger extract as an anticancer agent R Mukkavilli, C Yang, RS Tanwar, R Saxena, SR Gundala, Y Zhang, ... Scientific reports 8 (1), 3056, 2018 | 31 | 2018 |
| Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity M Henary, L Narayana, S Ahad, SR Gundala, R Mukkavilli, V Sharma, ... Biochemical pharmacology 92 (2), 192-205, 2014 | 28 | 2014 |
| Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases S Tan, H Yang, S Xue, J Qiao, M Salarian, K Hekmatyar, Y Meng, ... Science Advances 6 (6), eaav7504, 2020 | 20 | 2020 |
| In-vitro metabolism, CYP profiling and metabolite identification of E-and Z-guggulsterone, a potent hypolipidmic agent YS Chhonker, H Chandasana, V Bala, R Mukkavilli, D Kumar, S Vangala, ... Journal of Pharmaceutical and Biomedical Analysis 160, 202-211, 2018 | 16 | 2018 |
| Preclinical development of a non-toxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment GCRA Roopali Saxena, Chunhua Yang, Mukkavilli Rao, Ravi Chakra C Turaga ... Clinical Cancer Research, 45, 2017 | 13* | 2017 |
| Assessment of in vitro metabolic stability, plasma protein binding, and pharmacokinetics of E‐ and Z‐guggulsterone in rat YS Chhonker, H Chandasana, R Mukkavilli, YD Prasad, TS Laxman, ... Drug Testing and Analysis 8 (9), 966-975, 2016 | 11 | 2016 |
Subrahmanyam VangalaCEO, ReaGene Biosciences Pvt Ltd; CEO, InCan Solutions Pvt LtdVerified email at incansolutions.com
